Abstract
This chapter introduces the air-driven dielectric barrier discharge (DBD) based on the di_CAP technology-PlasmaDerm®. This plasma source received approval as medical device class IIa from the supervisory boards in Germany. The direct plasma generally is generated between two electrodes under atmospheric pressure. At least one of the two electrodes is completely covered by an electrical insulating material. The other electrode is usually the body surface to be treated. PlasmaDerm® activates the wound healing of the body and germ reducing reliably. The PlasmaDerm® product family is suitable for mobile treatment and care, since the devices are small, light and simple operate. Primary indications for PlasmaDerm® therapy are (chronic) wound-healing disorders such as acute wounds, venous and arterial ulcers, pressure sores, and the diabetic foot syndrome. More details and contact information is available on the company website: www.cinogy.de.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zenker M. Argon plasma coagulation. GMS Krankenhygiene Interdiszip. 2008;3(1.) Doc15. Published online 2008/11/03.
Daeschlein G, Scholz S, Ahmed R, von Woedtke T, Haase H, Niggemeier M, Kindel E, Brandenburg R, Weltmann KD, Juenger M. Skin decontamination by low-temperature atmospheric pressure plasma jet and dielectric barrier discharge plasma. J Hosp Infect. 2012;81(3):177–83.
Daeschlein G, Scholz S, Ahmed R, Majumdar A, von Woedtke T, Haase H, Niggemeier M, Kindel E, Brandenburg R, Weltmann KD, Jünger M. Cold plasma is well-tolerated and does not disturb skin barrier or reduce skin moisture. JDDG. 2012;10(7):509–15.
Rajasekaran P, Opländer C, Hoffmeister D, Bibinov N, Suschek CV, Wandke D, Awakowicz P. Characterization of dielectric barrier discharge (DBD) on mouse and histological evaluation of the plasma-treated tissue. Plasma Process Polym. 2011;8:246–55.
Daeschlein G, von Woedtke T, Kindel E, Brandenburg R, Weltmann KD, Jünger M. Antibacterial activity of atmospheric pressure plasma jet (APPJ) against relevant wound pathogens in vitro on simulated wound environment. Plasma Process Polym. 2009;6:224–30.
Daeschlein G, Scholz S, Arnold A, von Podewils S, Haase H, Emmert S, von Woedtke T, Weltmann KD, Jünger M. In vitro susceptibility of important skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD). Plasma Process Polym. 2012;9:380–9.
Daeschlein G, Scholz S, von Podewils S, Arnold A, Klare I, Haase H, Emmert S, von Woedtke T, Jünger M. Cold plasma—a new antimicrobial treatment tool against multidrug resistant pathogens. In: Mendez-Vilas A, editor. Worldwide research efforts in the fighting against microbial pathogens—from basic research to technological developments. Boca Raton: Brown Walker Press; 2013. p. 110–3.
Daeschlein G, Napp M, von Podewils S, Lutze S, Emmert S, Lange A, Klare I, Haase H, Gümbel D, von Woedtke T, Jünger M. In vitro susceptibility of multidrug resistant skin and wound pathogens against low temperature atmospheric pressure plasma jet (APPJ) and dielectric barrier discharge plasma (DBD). Plasma Process Polym. 2014;11:175–83.
Brehmer F, Haenssle HA, Daeschlein G, Ahmed R, Pfeiffer S, Görlitz A, Simon D, Schön MP, Wandke D, Emmert S. Alleviation of chronic venous leg ulcers with a hand-held dielectric barrier discharge plasma generator (PlasmaDerm® VU-2010): results of a monocentric, two-armed, open, prospective, randomized and controlled trial (NCT01415622). JEADV. 2016;29:148–55.
Emmert S, Brehmer F, Hänßle H, Helmke A, Mertens N, Ahmed R, Simon D, Wandke W, Maus-Friedrichs W, Daeschlein G, Schön MP, Viöl W. Atmospheric pressure plasma in dermatology: Ulcus treatment and much more. Clin Plasma Med. 2013; Epub 2013 Jan 2. https://doi.org/10.1016/j.cpme.2012.11.002.
Kisch T, Schleusser S, Helmke MKL, Wenzel ET, Hasemann B, Mailaender P, Kraemer R. The repetitive use of non-thermal dielectric barrier discharge plasma boosts cutaneous microcirculatory effects. Microvasc Res. 2016;106:8–13.
Kisch T, Helmke A, Schleusser S, Song J, Liodaki E, Stang FH, Mailaender P, Kraemer R. Improvement of cutaneous microcirculation by cold atmospheric plasma (CAP): results of a controlled, prospective cohort study. Microvasc Res. 2016;104:55–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Wandke, D. (2018). PlasmaDerm® - Based on di_CAP Technology. In: Metelmann, HR., von Woedtke, T., Weltmann, KD. (eds) Comprehensive Clinical Plasma Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-67627-2_33
Download citation
DOI: https://doi.org/10.1007/978-3-319-67627-2_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67626-5
Online ISBN: 978-3-319-67627-2
eBook Packages: MedicineMedicine (R0)